finding aat deficiency pizz genetic risk factor copd related high levels circulating aat polymers prompted measure serum levels polymers selected markers inflammation patients stable copd control subjects severe aat deficiency assess relationship genetic copd individuals n NUMBER independent significantly higher serum levels aat polymers vegf controls n30 subjects pizz copd n NUMBER showed significantly elevated serum levels seselectin sicam1 patients pimm copd n NUMBER showed higher levels vegf controls using factor analysis able split analysed biomarkers independent components containing mcp1 vegf polymers result binomial logistic regression showed NUMBER percent control individuals NUMBER percent copd patients correctly classified basis measured serum biomarkers observations highlight importance finding sets biomolecules offer new strategies diagnosis copd value monitoring progression copd alphal antitrypsin established age gender matched aat variant aat variant mmp NUMBER se selectin aat polymers sicam NUMBER mmp NUMBER il NUMBER mcp NUMBER mmp NUMBER il NUMBER second aat se selectin